Antibiotic Discovery and Development 2011
DOI: 10.1007/978-1-4614-1400-1_7
|View full text |Cite
|
Sign up to set email alerts
|

Aminoglycosides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
51
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(57 citation statements)
references
References 171 publications
1
51
0
Order By: Relevance
“…69 Advantages of the AGAs as parents for optimization include their broad spectrum of activity, their non-allergenic character, and their lack of effect on the host intestinal microbiome. 9 In addition, AGAs have physicochemical properties consistent with suggested guidelines for the development of new antibacterial compounds, 10 and following decades of use in the clinic, their PK, PD and ADME properties are well-understood and largely predictable. 9 Finally, existing AGAs are available on a large scale by fermentation, and their chemistry is well-documented, 1112 making them good candidates for optimization by chemical modification.…”
Section: Introductionmentioning
confidence: 99%
“…69 Advantages of the AGAs as parents for optimization include their broad spectrum of activity, their non-allergenic character, and their lack of effect on the host intestinal microbiome. 9 In addition, AGAs have physicochemical properties consistent with suggested guidelines for the development of new antibacterial compounds, 10 and following decades of use in the clinic, their PK, PD and ADME properties are well-understood and largely predictable. 9 Finally, existing AGAs are available on a large scale by fermentation, and their chemistry is well-documented, 1112 making them good candidates for optimization by chemical modification.…”
Section: Introductionmentioning
confidence: 99%
“…The bactericidal effect of this class is based on irreversibly binding to the aminoacyl site of the 16S rRNA within the bacterial 30S ribosomal subunits, resulting in mistranslation of the coding protein (Armstrong et al, 2012;Wright, 2010).…”
Section: Aminoglycosidesmentioning
confidence: 99%
“…Aminoglycoside resistance is widespread in E. coli isolates worldwide (Armstrong et al, 2012). Low levels of resistance to aminoglycosides: gentamicin (0% -3.1%); neomycin (2.1% -17.2%); spectinomycin (8.8% -27.7%); streptomycin (33.5% -34%) and apramycin ( …”
Section: Aminoglycosidesmentioning
confidence: 99%
“…Amikacin is a semi-synthetic aminoglycoside antibiotic synthesized by chemical modification of kanamycin A (Armstrong et al, 2012;Zawilla, Li, Hoogmartens, & Adams, 2007). Therefore, it belongs to the kanamycin subclass which includes kanamycin, tobramycin, and amikacin ( Figure 1).…”
Section: Introductionmentioning
confidence: 99%
“…Similar to other aminoglycosides, amikacin disrupts bacterial protein synthesis by binding to the 30S ribosome of susceptible organisms. Binding interferes with mRNA binding and tRNA acceptor sites, leading to the production of nonfunctional or toxic peptides (Armstrong et al, 2012).…”
Section: Introductionmentioning
confidence: 99%